The delivery of evidence-based preventive care for older Americans with arthritis

Arthritis Research and Therapy

Volumn 12, Issue 4, 2010, Pages

  Curtis, Jeffrey R ^a,b   Arora, Tarun ^b   Narongroeknawin, Pongthorn ^a   Taylor, Allison ^b   Bingham III, Clifton O ^c   Cush, Jack ^d   Saag, Kenneth G ^a,b   Safford, Monika ^e   Delzell, Elizabeth ^b  

^a The University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BAYLOR RESEARCH INSTITUTE   (United States)

^e University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTHRITIS; ARTICLE; COLONOSCOPY; DUAL ENERGY X RAY ABSORPTIOMETRY; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE DELIVERY; HEALTH SERVICE; HUMAN; HYPERLIPIDEMIA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MAMMOGRAPHY; MEDICARE; OSTEOARTHRITIS; PSORIATIC ARTHRITIS; SCREENING TEST; AGING; LONGITUDINAL STUDY; OUTCOME ASSESSMENT; PREVENTIVE MEDICINE; RHEUMATOID ARTHRITIS; STANDARD; STATISTICS; UNITED STATES;

AGED; AGED, 80 AND OVER; AGING; ARTHRITIS; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MEDICARE; OSTEOARTHRITIS; OUTCOME ASSESSMENT (HEALTH CARE); PREVENTIVE MEDICINE; UNITED STATES;

EID: 77954558813     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3086     Document Type: Article

References (47)

1. van Weel C, Schellevis FG. Comorbidity and guidelines: conflicting interests. Lancet 2006, 367:550-551. 10.1016/S0140-6736(06)68198-1, 16488782.
2. National Committee for Quality Assurance The State of Health Care Quality 2008. National Committee for Quality Assurance., http://www.ncqa.org/Portals/0/Newsroom/SOHC/SOHC_08.pdf
3. Curtis JR, Adachi JD, Saag KG. Bridging the osteoporosis quality chasm. J Bone Miner Res 2009, 24:3-7. 10.1359/jbmr.081116, 19016597.
4. Quick Reference Information Medicare Preventive Services. Quick Reference Information., http://www.cms.hhs.gov/MLNProducts/downloads/mps_guide_web-061305.pdf
5. National Osteoporosis Foundation Clinician's Guide to Prevention and Treatment of Osteoporosis. National Osteoporosis Foundation., http://www.nof.org/professionals/NOF_Clinicians_Guide.pdf
6. Physician Voluntary Reporting Program. , http://www.cms.hhs.gov/PQRI/Downloads/PVRPQualityMeasuresList.pdf
7. MacLean CH, Louie R, Leake B, McCaffrey DF, Paulus HE, Brook RH, Shekelle PG. Quality of care for patients with rheumatoid arthritis. JAMA 2000, 284:984-992. 10.1001/jama.284.8.984, 10944644.
8. Schneeweiss S, Setoguchi S, Weinblatt ME, Katz J, Avorn J, Sax P, Levin R, Solomon DH. Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in patients with rheumatoid arthritis. Arthritis Rheum 2007, 56:1754-64. 10.1002/art.22600, 17530704.
9. Wolfe F, Caplan L, Michaud K. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy. Arthritis Rheum 2006, 54:628-634. 10.1002/art.21568, 16447241.
10. Kanis JA, Johansson H, Oden A, Johnell O, de Laet C, Melton IL, Tenenhouse A, Reeve J, Silman AJ, Pols HA, Eisman JA, McCloskey EV, Mellstrom D. A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 2004, 19:893-899. 10.1359/JBMR.040134, 15125788.
11. Askling J, Baecklund E, Granath F, Geborek P, Fored M, Backlin C, Bertilsson L, Coster L, Jacobsson LT, Lindblad S, Lysholm J, Rantapaa-Dahlqvist S, Saxne T, van Vollenhoven R, Klareskog L, Feltelius N. Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register. Ann Rheum Dis 2009, 68:648-653. 10.1136/ard.2007.085852, 18467516.
12. Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L, Feltelius N, Coster L, Geborek P, Jacobsson LT, Lindblad S, Lysholm J, Rantapaa-Dahlqvist S, Saxne T, Klareskog L. Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists. Ann Rheum Dis 2005, 64:1421-1426. 10.1136/ard.2004.033993, 1755244, 15829572.
13. Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F, Catrina AI, Rosenquist R, Feltelius N, Sundstrom C, Klareskog L. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 2006, 54:692-701. 10.1002/art.21675, 16508929.
14. Smitten AL, Simon TA, Hochberg MC, Suissa S. A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis. Arthritis Res Ther 2008, 10:R45. 10.1186/ar2404, 2453765, 18433475.
15. Kremers HM, Crowson CS, Therneau TM, Roger VL, Gabriel SE. High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study. Arthritis Rheum 2008, 58:2268-2274. 10.1002/art.23650, 2929699, 18668561.
16. Nicola PJ, Crowson CS, Maradit-Kremers H, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE. Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis. Arthritis Rheum 2006, 54:60-67. 10.1002/art.21560, 16385496.
17. Nicola PJ, Maradit-Kremers H, Roger VL, Jacobsen SJ, Crowson CS, Ballman KV, Gabriel SE. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum 2005, 52:412-420. 10.1002/art.20855, 15692992.
18. Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, McInnes IB, Haentzschel H, Gonzalez-Gay MA, Provan S, Semb AG, Sidiropoulos P, Kitas G, Smulders YM, Soubrier MJ, Szekanecz Z, Sattar NG, Nurmohamed MT. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2009, 69:325-331. 10.1136/ard.2009.113696, 19773290.
19. Popa C, Netea MG, Radstake T, Van der Meer JW, Stalenhoef AF, van Riel PL, Barerra P. Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis. Ann Rheum Dis 2005, 64:303-305. 10.1136/ard.2004.023119, 1755332, 15231512.
20. Popa C, van den Hoogen FH, Radstake TR, Netea MG, Eijsbouts AE, den Heijer M, van der Meer JW, van Riel PL, Stalenhoef AF, Barrera P. Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis. Ann Rheum Dis 2007, 66:1503-1507. 10.1136/ard.2006.066191, 2111626, 17472994.
21. Spanakis E, Sidiropoulos P, Papadakis J, Ganotakis E, Katsikas G, Karvounaris S, Bizaki A, Kritikos H, Boumpas DT. Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab. J Rheumatol 2006, 33:2440-2446.
22. Als OS, Gotfredsen A, Christiansen C. The effect of glucocorticoids on bone mass in rheumatoid arthritis patients. Arthritis Rheum 1985, 28:369-375. 10.1002/art.1780280403, 3986005.
23. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 2001, 44:1496-1503. 10.1002/1529-0131(200107)44:7<1496::AID-ART271>3.0.CO;2-5, 11465699, American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
24. Eastell R, Devogelaer J, Peel NFA. Prevention of bone loss with risedronate in glucocorticoid-treated rheumatoid arthritis patients. Osteoporosis Int 2000, 11:331-337.
25. Katz JN, Barrett J, Liang MH, Bacon AM, Kaplan H, Kieval RI, Lindsey SM, Roberts WN, Sheff DM, Spencer RT, Weaver AL, Baron JA. Sensitivity and positive predictive value of Medicare Part B physician claims for rheumatologic diagnoses and procedures. Arthritis Rheum 1997, 40:1594-1600. 10.1002/art.1780400908, 9324013.
26. Singh JA, Holmgren AR, Noorbaloochi S. Accuracy of Veterans Administration databases for a diagnosis of rheumatoid arthritis. Arthritis Rheum 2004, 51:952-957. 10.1002/art.20827, 15593102.
27. Aday LA, Andersen R. A framework for the study of access to medical care. Health Serv Res 1974, 9:208-220. 1071804, 4436074.
28. Curtis JR, Carbone L, Cheng H, Hayes B, Laster A, Matthews R, Saag KG, Sepanski R, Tanner SB, Delzell E. Longitudinal trends in use of bone mass measurement among older americans, 1999-2005. J Bone Miner Res 2008, 23:1061-1067. 10.1359/jbmr.080232, 2497454,2497454, 18302495.
29. Harrington JT, Lease J. Osteoporosis disease management for fragility fracture patients: new understandings based on three years' experience with an osteoporosis care service. Arthritis Rheum 2007, 57:1502-1506. 10.1002/art.23093, 18050169.
30. Aizer J, Reed G, Onofrei A, Harrison MJ. Predictors of bone density testing in patients with rheumatoid arthritis. Rheumatol Int 2009, 29:897-905. 10.1007/s00296-008-0804-4, 19104820.
31. Kremers HM, Bidaut-Russell M, Scott CG, Reinalda MS, Zinsmeister AR, Gabriel SE. Preventive medical services among patients with rheumatoid arthritis. J Rheumatol 2003, 30:1940-1947.
32. Bili A, Schroeder LL, Ledwich LJ, Kirchner HL, Newman ED, Wasko MC. Patterns of preventive health services in rheumatoid arthritis patients compared to a primary care patient population. Rheumatol Int 2010,
33. Bridges MJ, Coady D, Kelly CA, Hamilton J, Heycock C. Factors influencing uptake of influenza vaccination in patients with rheumatoid arthritis. Ann Rheum Dis 2003, 62:685. 10.1136/ard.62.7.685, 1754592, 12810440.
34. Fahy WA, Farnworth E, Yeldrem KP, Melling GS, Grennan DM. Pneumococcal and influenza vaccination in patients with rheumatic conditions and receiving DMARD therapy. Rheumatology (Oxford) 2006, 45:912-913. 10.1093/rheumatology/kel104, 16638800.
35. Doe S, Pathare S, Kelly CA, Heycock CR, Binding J, Hamilton J. Uptake of influenza vaccination in patients on immunosuppressant agents for rheumatological diseases: a follow-up audit of the influence of secondary care. Rheumatology (Oxford) 2007, 46:715-716. 10.1093/rheumatology/kel410, 17244667.
36. Pradeep J, Watts R, Clunie G. Audit on the uptake of influenza and pneumococcal vaccination in patients with rheumatoid arthritis. Ann Rheum Dis 2007, 66:837-838. 10.1136/ard.2006.060285, 1954646, 17513572.
37. Sowden E, Mitchell WS. An audit of influenza and pneumococcal vaccination in rheumatology outpatients. BMC Musculoskelet Disord 2007, 8:58. 10.1186/1471-2474-8-58, 1949405, 17610723.
38. Lanternier F, Henegar C, Mouthon L, Blanche P, Guillevin L, Launay O. Low influenza-vaccination rate among adults receiving immunosuppressive therapy for systemic inflammatory disease. Ann Rheum Dis 2008, 67:1047. 10.1136/ard.2007.081703, 18556445.
39. Koutsogeorgopoulou L, Antoniadis C, Vassilopoulos D, Kassimos D. Preventive influenza vaccination for patients with rheumatoid arthritis. A need for an international campaign. Clin Rheumatol 2009, 28:103-104. 10.1007/s10067-008-1024-8, 18953623.
40. Teng GG, Curtis JR, Saag KG. Quality health care gaps in osteoporosis: how can patients, providers, and the health system do a better job?. Curr Osteoporos Rep 2009, 7:27-34. 10.1007/s11914-009-0006-3, 19239827.
41. Davis D, Thomson M, Oxman A, Haynes R. Changing physician performance: a systematic review of the effect of continuing medical education strategies. JAMA 1995, 274:700-705. 10.1001/jama.274.9.700, 7650822.
42. Thomson OaBrien M, Oxman A, Davis D, Haynes R, Freemantle N, Harvey E. Educational outreach visits: effects on professional practice and health care outcomes (Cochrane Review). The Cochrane Library 2004, Chichester, UK: John Wiley & Sons, Ltd.
43. Jamtvedt G, Young J, Kristoffersen D, Thomson OaBrien M, Oxman A. Audit and feedback: effects on professional practice and health care outcomes (Cochrane Review). The Cochrane Library 2004, Chichester, UK: John Wiley & Sons, Ltd.
44. Curtis JR, Westfall AO, Allison J, Becker A, Melton ME, Freeman A, Kiefe CI, MacArthur M, Ockershausen T, Stewart E, Weissman N, Saag KG. Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trial. Arch Intern Med 2007, 167:591-596. 10.1001/archinte.167.6.591, 17389291.
45. Colon-Emeric CS, Lyles KW, House P, Levine DA, Schenck AP, Allison J, Gorospe J, Fermazin M, Oliver K, Curtis JR, Weissman N, Xie A, Saag KG. Randomized trial to improve fracture prevention in nursing home residents. Am J Med 2007, 120:886-892. 10.1016/j.amjmed.2007.04.020, 2288656, 17904460.
46. Berwick D. Developing and Testing Changes in Delivery of Care. Ann Intern Med 1998, 128:651-656.
47. Newman ED, Harrington JT. Redesigning the care of rheumatic diseases at the practice and system levels. Part 2: system level process improvement (Redesign 201). Clin Exp Rheumatol 2007, 25:64-68.